Stent coverage and neointimal proliferation in bare metal stents postdilated with a paclitaxel-eluting balloon versus everolimus-eluting stents: Prospective randomized study using optical coherence tomography at 6-month follow-up

Circulation: Cardiovascular Interventions

Volumn 7, Issue 6, 2014, Pages 760-767

  Poerner, Tudor C ^a   Otto, Sylvia ^a   Gassdorf, Johannes ^a   Nitsche, Kristina ^a   Janiak, Florian ^a   Scheller, Bruno ^b   Goebel, Björn ^a   Jung, Christian ^a   Figulla, Hans R ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Coronary stenosis; Drug eluting stents; Percutaneous coronary intervention; Tomography optical coherence; Transluminal coronary balloon dilation

Indexed keywords

EVEROLIMUS; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PACLITAXEL; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; METALS; SIROLIMUS;

AGE; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON DILATATION; BARE METAL STENT; BARE METAL STENTING; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DRUG ELUTING CORONARY STENT; EVEROLIMUS DRUG ELUTING STENT; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; NEOINTIMAL PROLIFERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PTCA CATHETER; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RIGHT CORONARY ARTERY; SINGLE BLIND PROCEDURE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANGIOPLASTY, BALLOON, CORONARY; CELL PROLIFERATION; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG EFFECTS; DRUG-ELUTING STENTS; GERMANY; HUMANS; INSTRUMENTATION; MIDDLE AGED; NEOINTIMA; PATHOLOGY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RADIOGRAPHY; SINGLE-BLIND METHOD; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; GERMANY; HUMANS; MALE; METALS; MIDDLE AGED; NEOINTIMA; PACLITAXEL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SINGLE-BLIND METHOD; SIROLIMUS; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

EID: 84916896109     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.113.001146     Document Type: Article

References (33)

1. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol. 2008;97: 773-781.
2. Scheller B. Opportunities and limitations of drug-coated balloons in interventional therapies. Herz. 2011;36: 232-239.
3. Zeymer U, Scheller B. PCI in small vessels: The case for a drug-coated balloon based intervention. EuroIntervention. 2011;7(suppl K): K57-K60.
4. Liistro F, Porto I, Grotti S, Ventoruzzo G, Vergallo R, Bellandi G, Bolognese L. Drug-eluting balloon angioplasty for carotid in-stent restenosis. J Endovasc Ther. 2012;19: 729-733.
5. Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circulation. 1998;98: 1802-1820.
6. Serruys PW, Foley DP, Suttorp MJ, Rensing BJ, Suryapranata H, Materne P, van den Bos A, Benit E, Anzuini A, Rutsch W, Legrand V, Dawkins K, Cobaugh M, Bressers M, Backx B, Wijns W, Colombo A. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: Final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. J Am Coll Cardiol. 2002;39: 393-399.
7. van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. 2002;39: 559-564.
8. Nakatani M, Takeyama Y, Shibata M, Yorozuya M, Suzuki H, Koba S, Katagiri T. Mechanisms of restenosis after coronary intervention: Difference between plain old balloon angioplasty and stenting. Cardiovasc Pathol. 2003;12: 40-48.
9. Kleber FX, Rittger H, Bonaventura K, Zeymer U, Wöhrle J, Jeger R, Levenson B, Möbius-Winkler S, Bruch L, Fischer D, Hengstenberg C, Pörner T, Mathey D, Scheller B. Drug-coated balloons for treatment of coronary artery disease: Updated recommendations from a consensus group. Clin Res Cardiol. 2013;102: 785-797.
10. Gutiérrez-Chico JL, van Geuns RJ, Koch KT, Koolen JJ, Duckers H, Regar E, Serruys PW. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: An optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. EuroIntervention. 2011;7: 711-722.
11. Ali RM, Degenhardt R, Zambahari R, Tresukosol D, Ahmad WA, Kamar Hb, Kui-Hian S, Ong TK, bin Ismail O, bin Elis S, Udychalerm W, Ackermann H, Boxberger M, Unverdorben M. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxeleluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention. 2011;7(suppl K): K83-K92.
12. Pöss J, Jacobshagen C, Ukena C, Böhm M. Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld-BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis. Clin Res Cardiol. 2010;99: 411-417.
13. Poerner TC, Otto S, Gassdorf J, Janiak F, Danzer C, Ferrari M, Figulla HR. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): Rationale, design and methods. EuroIntervention. 2011;7(suppl K): K93-K99.
14. Task Force on Myocardial Revascularization of the European Society of C, The European Association for Cardio-Thoracic S, European Association for Percutaneous Cardiovascular I, Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2010;38(suppl): S1-S52.
15. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxelcoated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119: 2986-2994.
16. Bocksch W, Pomar F, Dziarmaga M, Tresukosol D, Ismail O, Janek B, Carlsson J, Simon JP; Coroflex Blue Registry Investigators. Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: Results of the real world Coroflex Blue Registry. Catheter Cardiovasc Interv. 2010;75: 78-85.
17. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, Sawada T, Paredes OL, Hirata K, Yokoyama M. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: Evaluated by optical coherence tomography. Eur Heart J. 2007;28: 961-967.
18. Gibson CM, Kuntz RE, Nobuyoshi M, Rosner B, Baim DS. Lesionto-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of lesion-based restenosis analysis. Circulation. 1993;87: 1123-1129.
19. Kastrati A, Schömig A, Elezi S, Schühlen H, Wilhelm M, Dirschinger J. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions. Circulation. 1998;97: 2396-2401.
20. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: An autopsy study. Circulation. 2008;118: 1138-1145.
21. Kim S, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Cho YK, Nam CW, Hur SH, Jang Y, Hong MK. Comparison of early strut coverage between zotarolimus-and everolimus-eluting stents using optical coherence tomography. Am J Cardiol. 2013;111: 1-5.
22. Gutiérrez-Chico JL, Wykrzykowska J, Nüesch E, van Geuns RJ, Koch KT, Koolen JJ, di Mario C, Windecker S, van Es GA, Gobbens P, Jüni P, Regar E, Serruys PW. Vascular tissue reaction to acute malapposition in human coronary arteries: Sequential assessment with optical coherence tomography. Circ Cardiovasc Interv. 2012;5: 20-29.
23. Gutiérrez-Chico JL, Regar E, Nüesch E, Okamura T, Wykrzykowska J, di Mario C, Windecker S, van Es GA, Gobbens P, Jüni P, Serruys PW. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: In vivo assessment with optical coherence tomography. Circulation. 2011;124: 612-623.
24. Radu M, Jørgensen E, Kelbæk H, Helqvist S, Skovgaard L, Saunamäki K. Optical coherence tomography at follow-up after percutaneous coronary intervention: Relationship between procedural dissections, stent strut malapposition and stent healing. EuroIntervention. 2011;7: 353-361.
25. Fischer D, Scheller B, Schäfer A, Klein G, Böhm M, Clever Y, Cremers B. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: An IVUS study. EuroIntervention. 2012;8: 450-455.
26. Clever YP, Cremers B, Speck U, Dietz U, Böhm M, Scheller B. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: Comparison with a drug eluting stent and a bare metal stent. Catheter Cardiovasc Interv. 2014;84: 323-331.
27. Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ; SPIRIT IV Investigators. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med. 2010;362: 1663-1674.
28. Jensen LO, Thayssen P, Hansen HS, Christiansen EH, Tilsted HH, Krusell LR, Villadsen AB, Junker A, Hansen KN, Kaltoft A, Maeng M, Pedersen KE, Kristensen SD, Bøtker HE, Ravkilde J, Sanchez R, Aarøe J, Madsen M, Sørensen HT, Thuesen L, Lassen JF; Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV) Investigators. Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: The Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV). Circulation. 2012;125: 1246-1255.
29. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57: 1314-1322.
30. Horita Y, Ikeda M, Inoki I, Namura M, Sakata K, Terai H. Tct-638 late catchup restenosis of drug eluting stents: Evidence from comparison with bare metal stents in japanese cad patients. J Am Coll Cardiol. 2012; 60: 17-S. 31. Fröhlich GM, Lansky AJ, Ko DT, Archangelidi O, De Palma R, Timmis A, Meier P. Drug eluting balloons for de novo coronary lesions-A systematic review and meta-analysis. BMC Med. 2013;11: 123.
31. Valgimigli M, Campo G, Monti M, Vranckx P, Percoco G, Tumscitz C, Castriota F, Colombo F, Tebaldi M, Fucà G, Kubbajeh M, Cangiano E, Minarelli M, Scalone A, Cavazza C, Frangione A, Borghesi M, Marchesini J, Parrinello G, Ferrari R; Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators. Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial. Circulation. 2012;125: 2015-2026.
32. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297: 159-168.
33. Park SJ, Park DW, Kim YH, Kang SJ, Lee SW, Lee CW, Han KH, Park SW, Yun SC, Lee SG, Rha SW, Seong IW, Jeong MH, Hur SH, Lee NH, Yoon J, Yang JY, Lee BK, Choi YJ, Chung WS, Lim DS, Cheong SS, Kim KS, Chae JK, Nah DY, Jeon DS, Seung KB, Jang JS, Park HS, Lee K. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med. 2010;362: 1374-1382.